{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:34:46Z","timestamp":1790310886455,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T00:00:00Z","timestamp":1480032000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Research Project Supported by Health and Family Planning Commission of Shanxi Province Scholarship in China","award":["2015052"],"award-info":[{"award-number":["2015052"]}]},{"name":"the Wu Jieping Medical Foundation","award":["320.6750.12693"],"award-info":[{"award-number":["320.6750.12693"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10585-016-9822-x","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T04:18:59Z","timestamp":1480047539000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China"],"prefix":"10.1007","volume":"34","author":[{"given":"Hongwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songye","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenming","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,25]]},"reference":[{"key":"9822_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108","journal-title":"CA Cancer J Clin"},{"key":"9822_CR2","first-page":"391","volume":"33","author":"S Chang","year":"2012","unstructured":"Chang S, Dai M, Ren JS, Chen YH, Guo LW (2012) Estimates and prediction on incidence, mortality and prevalence of lung cancer in China in 2008. Zhonghua Liu Xin Bing Xue Za Zhi 33:391\u2013394 in Chinese","journal-title":"Zhonghua Liu Xin Bing Xue Za Zhi"},{"issue":"7517","key":"9822_CR3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/513S2a","volume":"513","author":"E Bender","year":"2014","unstructured":"Bender E (2014) Epidermiology: the dorminant malignancy. Nature 513(7517):S2\u2013S3","journal-title":"Nature"},{"key":"9822_CR4","first-page":"2892","volume":"5","author":"A Midha","year":"2015","unstructured":"Midha A, Dearden S, McCormack R (2015) EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII). Am J Cancer Res 5:2892\u20132911","journal-title":"Am J Cancer Res"},{"key":"9822_CR5","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/annonc\/mdt205","volume":"24","author":"S Dearden","year":"2013","unstructured":"Dearden S, Stevens J, Wu YL, Blowers D (2013) Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap). Ann Oncol 24:2371\u20132376","journal-title":"Ann Oncol"},{"key":"9822_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","volume":"13","author":"R Rosell","year":"2012","unstructured":"Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia-Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre R, Bover I, Illiano A, Dansin E, de Castro J, Milella M, Reguart N, Altavilla G, Jimenez U, Provencio M, Moreno MA, Terrasa J, Mu\u00f1oz-Langa J, Valdivia J, Isla D, Domine M, Molinier O, Mazieres J, Baize N, Garcia-Campelo R, Robinet G, Rodriguez-Abreu D, Lopez-Vivanco G, Gebbia V, Ferrera-Delgado L, Bombaron P, Bernabe R, Bearz A, Artal A, Cortesi E, Rolfo C, Sanchez-Ronco M, Drozdowskyj A, Queralt C, de Aguirre I, Ramirez JL, Sanchez JJ, Molina MA, Taron M, Paz-Ares L (2012) Spanish Lung Cancer Group in collaboration with Groupe Fran\u00e7ais de Pneumo-Canc\u00e9rologie and Associazione Italiana Oncologia Toracica. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small cell lung cancer (EURTAC): a multicentre, open label, randomized phase 3 trial. Lancet Oncol 13:239\u2013246","journal-title":"Lancet Oncol"},{"key":"9822_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.lungcan.2013.11.021","volume":"83","author":"JC Yang","year":"2014","unstructured":"Yang JC, Wu YL, Chan V, Kurnianda J, Nakagawa K, Saijo N, Fukuoka M, McWalter G, McCormack R, Mok TS (2014) Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-Asia Study (IPASS). Lung Cancer 83:174\u2013181","journal-title":"Lung Cancer"},{"key":"9822_CR8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","volume":"12","author":"C Zhou","year":"2011","unstructured":"Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C, Zhang S, Wang J, Zhou S, Ren S, Lu S, Zhang L, Hu C, Hu C, Luo Y, Chen L, Ye M, Huang J, Zhi X, Zhang Y, Xiu Q, Ma J, Zhang L, You C (2011) Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, openlabel, randomised, phase 3 study. Lancet Oncol 12:735\u2013742","journal-title":"Lancet Oncol"},{"key":"9822_CR9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12253-013-9667-4","volume":"20","author":"P Krawczyk","year":"2014","unstructured":"Krawczyk P, Nico\u015b M, Ramlau R, Powrozek T, Wojas-Krawczyk K, Sura S, Jarosz B, Warda E, Mazurkiewicz T, Sawicki M, Milanowski J (2014) The incidence of EGFR-activating mutations in bone metastases of lung adenocarcinoma. Pathol Oncol Res 20:107\u2013112","journal-title":"Pathol Oncol Res"},{"key":"9822_CR10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1007\/s12032-015-0714-8","volume":"33","author":"J Guan","year":"2016","unstructured":"Guan J, Chen M, Xiao N, Li L, Zhang Y, Li Q, Yang M, Liu L, Chen L (2016) EGFR mutations are associated with higher incidence of distant metastases and smaller tumor size in patients with non-small-cell lung cancer based on PET\/CT scan. Med Oncol 33:e1\u2013e8","journal-title":"Med Oncol"},{"key":"9822_CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.resinv.2013.02.004","volume":"51","author":"Y Enomoto","year":"2013","unstructured":"Enomoto Y, Takada K, Hagiwara E, Kojima E (2013) Distinct features of distant metastasis and lymph node stage in lung adenocarcinoma patients with epidermal growth factor receptor gene mutations. Respir Investig 51:153\u2013157","journal-title":"Respir Investig"},{"key":"9822_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.lungcan.2014.01.006","volume":"84","author":"LE Hendriks","year":"2014","unstructured":"Hendriks LE, Smit EF, Vosse BA, Mellema WW, Heideman DA, Bootsma GP, Westenend M, Pitz C, de Vries GJ, Houben R, Gr\u00fcnberg K, Bendek M, Speel EJ, Dingemans AM (2014) EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? Lung Cancer 84:86\u201391","journal-title":"Lung Cancer"},{"issue":"21","key":"9822_CR13","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350(21):2129\u20132139","journal-title":"N Engl J Med"},{"key":"9822_CR14","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1093\/nar\/17.7.2503","volume":"17","author":"CR Newton","year":"1989","unstructured":"Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF (1989) Analysis of any point mutation in DNA: the amplification refractory mutation system (ARMS). Nucleic Acids Res 17:2503\u20132516","journal-title":"Nucleic Acids Res"},{"key":"9822_CR15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1947601912465177","volume":"3","author":"A El-Telbany","year":"2012","unstructured":"El-Telbany A, Ma PC (2012) Cancer genes in lung cancer: racial disparities: are there any? Genes Cancer 3:467\u2013480","journal-title":"Genes Cancer"},{"key":"9822_CR16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrc2190","volume":"7","author":"S Sun","year":"2007","unstructured":"Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers\u2013a different disease. Nat Rev Cancer 7:778\u2013790","journal-title":"Nat Rev Cancer"},{"key":"9822_CR17","doi-asserted-by":"crossref","first-page":"e56011","DOI":"10.1371\/journal.pone.0056011","volume":"8","author":"YL Choi","year":"2013","unstructured":"Choi YL, Sun JM, Cho J et al (2013) EGFR mutation testing in patients with advanced non small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital. PLoS One 8:e56011","journal-title":"PLoS One"},{"key":"9822_CR18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.lungcan.2014.02.006","volume":"84","author":"JS Cos Escu\u00edn de","year":"2014","unstructured":"de Cos Escu\u00edn JS, Arca JA, \u00cd\u00f1iguez RM, Sorribes LM, Ares AN, Hern\u00e1ndez JRH, Arang\u00fcena LG, Delgado MN, Fern\u00e1ndez MJP, Corral GF, de Esteban J\u00falvez L, Budi\u00f1o MTG, Cavaco FA, Barrera EA, Garc\u00eda FA, Mitjans MS, Rodr\u00edguez HH (2014) Tumor, node and metastasis classification of lung cancer\u2014M1a versus M1b\u2014analysis of M descriptors and other prognostic factors. Lung Cancer 84:182\u2013189","journal-title":"Lung Cancer"},{"key":"9822_CR19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10585-014-9648-3","volume":"31","author":"D Fujimoto","year":"2014","unstructured":"Fujimoto D, Ueda H, Shimizu R, Kato R, Otoshi T, Kawamura T, Tamai K, Shibata Y, Matsumoto T, Nagata K, Otsuka K, Nakagawa A, Otsuka K, Katakami N, Tomii K (2014) Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis. Clin Exp Metastasis 31:543\u2013551","journal-title":"Clin Exp Metastasis"},{"key":"9822_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(14)71173-8","volume":"16","author":"JC Yang","year":"2015","unstructured":"Yang JC, Wu YL, Schuler M, Sebastian M, Popat S, Yamamoto N, Zhou C, Hu CP, O\u2019Byrne K, Feng J, Lu S, Huang Y, Geater SL, Lee KY, Tsai CM, Gorbunova V, Hirsh V, Bennouna J, Orlov S, Mok T, Boyer M, Su WC, Lee KH, Kato T, Massey D, Shahidi M, Zazulina V, Sequist LV (2015) Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomized, phase 3 trials. Lancet Oncol 16:141\u2013151","journal-title":"Lancet Oncol"},{"key":"9822_CR21","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","volume":"94","author":"LJ Schouten","year":"2002","unstructured":"Schouten LJ, Rutten J, Huveneers HAM, Twijnstra A (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94:2698\u20132705","journal-title":"Cancer"},{"key":"9822_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","volume":"9","author":"DY Shin","year":"2014","unstructured":"Shin DY, Na II, Kim CH, Park S, Baek H, Yang SH (2014) EGFR mutation and brain metastasis in pulmonary adenocarcinomas. J Thorac Oncol 9:195\u2013199","journal-title":"J Thorac Oncol"},{"key":"9822_CR23","first-page":"1258","volume":"118","author":"KJ Cao","year":"2005","unstructured":"Cao KJ, Huang HY, Tu MC, Pan GY (2005) Long-term results of prophylactic cranial irradiation for limited-staged small-cell lung cancer in complete remission. Chin Med J 118:1258\u20131262","journal-title":"Chin Med J"},{"key":"9822_CR24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa071780","volume":"357","author":"B Slotman","year":"2007","unstructured":"Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E, Senan S (2007) EORTC radiation oncology group and lung cancer group. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357:664\u2013672","journal-title":"N Engl J Med"},{"key":"9822_CR25","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1093\/annonc\/mds123","volume":"23","author":"SE Schild","year":"2012","unstructured":"Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group (2012) Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol 23:2919\u20132924","journal-title":"Ann Oncol"},{"key":"9822_CR26","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.1200\/JCO.2007.12.5468","volume":"25","author":"C P\u00f6ttgen","year":"2007","unstructured":"P\u00f6ttgen C, Eberhardt W, Grannass A, Korfee S, St\u00fcben G, Teschler H, Stamatis G, Wagner H, Passlick B, Petersen V, Budach V, Wilhelm H, Wanke I, Hirche H, Wilke HJ, Stuschke M (2007) Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. J Clin Oncol 25:4987\u20134992","journal-title":"J Clin Oncol"},{"key":"9822_CR27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2010.29.1609","volume":"29","author":"EM Gore","year":"2011","unstructured":"Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H (2011) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. J Clin Oncol 29:272\u2013278","journal-title":"J Clin Oncol"},{"key":"9822_CR28","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.ijrobp.2012.07.169","volume":"84","author":"EM Gore","year":"2012","unstructured":"Gore EM, Gore EM, Bae K, Wong SJ, Sun A, Bonner JA, Schild SE, Gaspar LE, Bogart JA, Werner-Wasik M, Choy H (2012) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer\u2014an updated analysis of RTOG 0214. Int J Radiat Oncol Biol Phys 84:S103","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9822_CR29","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1002\/ijc.25639","volume":"128","author":"A Ho-Pun-Cheung","year":"2011","unstructured":"Ho-Pun-Cheung A, Assenat E, Bascoul-Mollevi C, Bibeau F, Boissi\u00e8re-Michot F, Cellier D, Azria D, Rouanet P, Senesse P, Ychou M, Lopez-Crapez E (2011) EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer. Int J Cancer 128:2938\u20132946","journal-title":"Int J Cancer"},{"key":"9822_CR30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/jcp.21260","volume":"214","author":"A Luca De","year":"2008","unstructured":"De Luca A, Carotenuto A, Rachiglio A, Gallo M, Maiello MR, Aldinucci D, Pinto A, Normanno N (2008) The role of the EGFR signaling in tumor microenvironment. J Cell Physiol 214:559\u2013567","journal-title":"J Cell Physiol"},{"key":"9822_CR31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2119\/molmed.2011.00115","volume":"17","author":"M Mimeault","year":"2011","unstructured":"Mimeault M, Batra SK (2011) Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies. Mol Med 17:949\u2013964","journal-title":"Mol Med"},{"key":"9822_CR32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1470-2045(06)70868-3","volume":"7","author":"F Blanchon","year":"2006","unstructured":"Blanchon F, Grivaux M, Asselain B, Lebas FX, Orlando JP, Piquet J, Zureik M (2006) 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol 7:829\u2013836","journal-title":"Lancet Oncol"},{"key":"9822_CR33","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/cncr.24133","volume":"115","author":"JM Varlotto","year":"2009","unstructured":"Varlotto JM, Recht A, Flickinger JC, Medford-Davis LN, Dyer AM, Decamp MM (2009) Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer. Cancer 115:1059\u20131069","journal-title":"Cancer"},{"key":"9822_CR34","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1002\/cncr.25254","volume":"116","author":"JL Hubbs","year":"2010","unstructured":"Hubbs JL, Boyd JA, Hollis D, Chino JP, Saynak M, Kelsey CR (2010) Factors associated with the development of brain metastases: analysis of 975 patients with early stage nonsmall cell lung cancer. Cancer 116:5038\u20135046","journal-title":"Cancer"},{"issue":"3","key":"9822_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.lungcan.2015.03.020","volume":"88","author":"CP Simmons","year":"2015","unstructured":"Simmons CP, Koinis F, Fallon MT, Fearon KC, Bowden J, Solheim TS, Gronberg BH, McMillan DC, Gioulbasanis I, Laird BJ (2015) Prognosis in advanced lung cancer\u2014a prospective study examining key clinicopathological factors. Lung Cancer 88(3):304\u2013309. doi: 10.1016\/j.lungcan.2015.03.020","journal-title":"Lung Cancer"},{"issue":"6","key":"9822_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cllc.2014.06.006","volume":"15","author":"YY He","year":"2014","unstructured":"He YY, Zhang XC, Yang JJ, Niu FY, Zeng Z, Yan HH, Xu CR, Guan JL, Zhong WZ, Yang LL, Guo LH, Wu YL (2014) Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer. Clin Lung Cancer 15(6):441\u2013447. doi: 10.1016\/j.cllc.2014.06.006","journal-title":"Clin Lung Cancer"},{"issue":"15","key":"9822_CR37","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1158\/1078-0432.CCR-08-2921","volume":"15","author":"M Sun","year":"2009","unstructured":"Sun M, Behrens C, Feng L, Ozburn N, Tang X, Yin G, Komaki R, Varella-Garcia M, Hong WK, Aldape KD, Wistuba II (2009) HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors. Clin Cancer Res 15(15):4829\u20134837","journal-title":"Clin Cancer Res"},{"issue":"4","key":"9822_CR38","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdn679","volume":"20","author":"CH Gow","year":"2009","unstructured":"Gow CH, Chang YL, Hsu YC, Tsai MF, Wu CT, Yu CJ, Yang CH, Lee YC, Yang PC, Shih JY (2009) Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer. Ann Oncol 20(4):696\u2013702","journal-title":"Ann Oncol"},{"key":"9822_CR39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1148\/radiol.2422052090","volume":"242","author":"RM Lindell","year":"2007","unstructured":"Lindell RM, Hartman TE, Swensen SJ, Jett JR, Midthun DE, Tazelaar HD, Mandrekar JN (2007) Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology 242:555\u2013562","journal-title":"Radiology"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-016-9822-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-016-9822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:29:09Z","timestamp":1498350549000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-016-9822-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,25]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["9822"],"URL":"https:\/\/doi.org\/10.1007\/s10585-016-9822-x","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,25]]}}}